{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:18:20Z","timestamp":1788412700328,"version":"build-2803163510"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40119-026-00454-8","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:15:54Z","timestamp":1778638554000},"page":"377-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiogenic Shock Centers and Protocols for Acute Cardiovascular Care: Bridging the Gap Between Spoke and Hub Sites"],"prefix":"10.1007","volume":"15","author":[{"given":"Chirag","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahas","family":"Chandragiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Asnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sweeting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari S.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Dawn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-8238","authenticated-orcid":false,"given":"Saraschandra","family":"Vallabhajosyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"16","key":"454_CR1","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232\u201368.","journal-title":"Circulation."},{"issue":"3","key":"454_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jcin.2021.12.016","volume":"15","author":"S Vallabhajosyula","year":"2022","unstructured":"Vallabhajosyula S. Trials, tribunals, and opportunities in cardiogenic shock research. JACC Cardiovasc Interv. 2022;15(3):305\u20137.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"454_CR3","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.mayocp.2022.06.027","volume":"97","author":"S Vallabhajosyula","year":"2022","unstructured":"Vallabhajosyula S, Verghese D, Henry TD, et al. Contemporary management of concomitant cardiac arrest and cardiogenic shock complicating myocardial infarction. Mayo Clin Proc. 2022;97(12):2333\u201354.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"454_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/SHK.0000000000001895","volume":"57","author":"S Vallabhajosyula","year":"2022","unstructured":"Vallabhajosyula S, Dewaswala N, Sundaragiri PR, et al. Cardiogenic shock complicating ST-segment elevation myocardial infarction: an 18-year analysis of temporal trends, epidemiology, management, and outcomes. Shock. 2022;57(3):360\u20139.","journal-title":"Shock"},{"issue":"16","key":"454_CR5","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.jacc.2018.07.074","volume":"72","author":"T Rab","year":"2018","unstructured":"Rab T, Ratanapo S, Kern KB, et al. Cardiac shock care centers: JACC review topic of the week. J Am Coll Cardiol. 2018;72(16):1972\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"454_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1206570","volume":"10","author":"M Alvarez Villela","year":"2023","unstructured":"Alvarez Villela M, Fu D, Roslin K, et al. Defining levels of care in cardiogenic shock. Front Cardiovasc Med. 2023;10:1206570.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"454_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012477","volume":"18","author":"S Pawar","year":"2025","unstructured":"Pawar S, Bansal K, Abbott JD, et al. Transfer to hub hospitals and outcomes in cardiogenic shock. Circ Heart Fail. 2025;18(4):e012477.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"454_CR8","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/ejhf.2263","volume":"23","author":"DY Lu","year":"2021","unstructured":"Lu DY, Adelsheimer A, Chan K, et al. Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world. Eur J Heart Fail. 2021;23(11):1927\u201337.","journal-title":"Eur J Heart Fail"},{"key":"454_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jchf.2022.04.004","volume":"10","author":"BN Tehrani","year":"2022","unstructured":"Tehrani BN, Sherwood MW, Rosner C, Truesdell AG, Ben Lee S, Damluji AA, et al. A standardized and regionalized network of care for cardiogenic shock. JACC Heart Fail. 2022;10:768\u201381.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"454_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14797\/mdcj-16-1-50","volume":"16","author":"MM Patarroyo Aponte","year":"2020","unstructured":"Patarroyo Aponte MM, Manrique C, Kar B. Systems of care in cardiogenic shock. Methodist Debakey Cardiovasc J. 2020;16(1):50\u20136.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"13","key":"454_CR11","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jacc.2021.07.044","volume":"78","author":"AI Papolos","year":"2021","unstructured":"Papolos AI, Kenigsberg BB, Berg DD, et al. Management and outcomes of cardiogenic shock in cardiac ICUs with versus without shock teams. J Am Coll Cardiol. 2021;78(13):1309\u201317.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"454_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.119.040654","volume":"140","author":"I Taleb","year":"2019","unstructured":"Taleb I, Koliopoulou AG, Tandar A, et al. Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of concept. Circulation. 2019;140(1):98\u2013100.","journal-title":"Circulation"},{"issue":"13","key":"454_CR13","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jacc.2018.12.084","volume":"73","author":"BN Tehrani","year":"2019","unstructured":"Tehrani BN, Truesdell AG, Sherwood MW, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol. 2019;73(13):1659\u201369. https:\/\/doi.org\/10.1016\/j.jacc.2018.12.084. (Erratum in: J Am Coll Cardiol. 2019 Jul 23;74(3):481.)","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"454_CR14","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/jcm13072101","volume":"13","author":"L Belfioretti","year":"2024","unstructured":"Belfioretti L, Francioni M, Battistoni I, et al. Evolution of cardiogenic shock management and development of a multidisciplinary team-based approach: ten years experience of a single center. J Clin Med. 2024;13(7):2101.","journal-title":"J Clin Med"},{"key":"454_CR15","doi-asserted-by":"crossref","unstructured":"Tehrani B, Truesdell A, Singh R, Murphy C, Saulino P. Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry): Observational and Retrospective Study. JMIR Res Protoc. 2018;7(6):e160","DOI":"10.2196\/resprot.9761"},{"issue":"5","key":"454_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.011630","volume":"18","author":"V Blumer","year":"2025","unstructured":"Blumer V, Hanff TC, Gage A, Schrage B, Kanwar MK. Cardiogenic shock teams: past, present, and future directions. Circ Heart Fail. 2025;18(5):e011630.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"454_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cjco.2020.03.009","volume":"2","author":"F Lee","year":"2020","unstructured":"Lee F, Hutson JH, Boodhwani M, McDonald B, So D, De Roock S, et al. Multidisciplinary code shock team in cardiogenic shock: a Canadian centre experience. CJC Open. 2020;2(4):249\u201357.","journal-title":"CJC Open"},{"issue":"10","key":"454_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jchf.2022.04.004","volume":"10","author":"BN Tehrani","year":"2022","unstructured":"Tehrani BN, Sherwood MW, Rosner C, et al. A standardized and regionalized network of care for cardiogenic shock. JACC Heart Fail. 2022;10(10):768\u201381.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"454_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031979","volume":"13","author":"B Senman","year":"2024","unstructured":"Senman B, Jentzer JC, Barnett CF, et al. Need for a cardiogenic shock team collaborative-promoting a team-based model of care to improve outcomes and identify best practices. J Am Heart Assoc. 2024;13(6):e031979.","journal-title":"J Am Heart Assoc"},{"key":"454_CR20","doi-asserted-by":"crossref","unstructured":"Basir MB, Kapur NK, Patel K, et al. Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv. 2019;93(7):1173\u201383.","DOI":"10.1002\/ccd.28307"},{"issue":"4","key":"454_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cardfail.2023.09.003","volume":"30","author":"AR Garan","year":"2024","unstructured":"Garan AR, Kataria R, Li B, Sinha S, et al. Outcomes of patients transferred to tertiary care centers for treatment of cardiogenic shock: a Cardiogenic Shock Working Group analysis. J Card Fail. 2024;30(4):564\u201375.","journal-title":"J Card Fail"},{"issue":"16","key":"454_CR22","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jacc.2025.02.018","volume":"85","author":"SS Sinha","year":"2025","unstructured":"Sinha SS, Morrow DA, Kapur NK, Kataria R, Roswell RO. Concise clinical guidance: an ACC expert consensus statement on the evaluation and management of cardiogenic shock: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2025;85(16):1618\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"454_CR23","first-page":"29","volume":"94","author":"DA Baran","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019;94(1):29\u201337.","journal-title":"Catheter Cardiovasc Interv"},{"key":"454_CR24","unstructured":"Kapur NK, Kanwar M, Sinha SS, et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):976\u201381."},{"issue":"9","key":"454_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.amjcard.2017.07.038","volume":"120","author":"M Vives-Borr\u00e1s","year":"2017","unstructured":"Vives-Borr\u00e1s M, Moustafa AH, \u00c1lvarez-Garc\u00eda J, et al. Clinical and prognostic value of the electrocardiogram in patients with acute occlusion of the left circumflex coronary artery. Am J Cardiol. 2017;120(9):1487\u201394.","journal-title":"Am J Cardiol"},{"issue":"2","key":"454_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjcard.2008.09.008","volume":"103","author":"RA Aqel","year":"2009","unstructured":"Aqel RA, Hage FG, Ellipeddi P, et al. Usefulness of three posterior chest leads for the detection of posterior wall acute myocardial infarction. Am J Cardiol. 2009;103(2):159\u201364.","journal-title":"Am J Cardiol"},{"issue":"22","key":"454_CR27","first-page":"e368","volume":"144","author":"M Gulati","year":"2021","unstructured":"Gulati M, Levy PD, Mukherjee D, et al. AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368\u2013454.","journal-title":"Circulation"},{"issue":"3","key":"454_CR28","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.chest.2023.09.029","volume":"165","author":"A Longino","year":"2024","unstructured":"Longino A, Martin K, Leyba K, et al. Prospective evaluation of venous excess ultrasound for estimation of venous congestion. Chest. 2024;165(3):590\u2013600.","journal-title":"Chest"},{"issue":"1","key":"454_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13054-023-04471-0","volume":"27","author":"A Longino","year":"2023","unstructured":"Longino A, Martin K, Leyba K, et al. Correlation between the VExUS score and right atrial pressure: a pilot prospective observational study. Crit Care. 2023;27(1):205.","journal-title":"Crit Care"},{"issue":"24","key":"454_CR30","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.3390\/jcm11247538","volume":"11","author":"MC Pastore","year":"2022","unstructured":"Pastore MC, Ilardi F, Stefanini A, et al. Bedside ultrasound for hemodynamic monitoring in cardiac intensive care unit. J Clin Med. 2022;11(24):7538.","journal-title":"J Clin Med"},{"issue":"4","key":"454_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/jcm14041334","volume":"14","author":"A Campos-S\u00e1enz de Santamar\u00eda","year":"2025","unstructured":"Campos-S\u00e1enz de Santamar\u00eda A, Albines Fiestas ZS, Crespo-Aznarez S, et al. VExUS protocol along cardiorenal syndrome: an updated review. J Clin Med. 2025;14(4):1334.","journal-title":"J Clin Med"},{"key":"454_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155097","volume":"88","author":"P Klompmaker","year":"2025","unstructured":"Klompmaker P, Mousa A, Allard DJ, et al. The association between venous excess ultrasound grading system (VExUS) and major adverse kidney events after 30 days in critically ill patients: a prospective cohort study. J Crit Care. 2025;88:155097.","journal-title":"J Crit Care"},{"issue":"9","key":"454_CR33","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jum.16709","volume":"44","author":"CJ Espinosa-Almanza","year":"2025","unstructured":"Espinosa-Almanza CJ, Ruiz-\u00c1vila HA, Gomez-Tobar JE, Acosta-Guti\u00e9rrez E. Relationship between cumulative fluid balance and the degree of venous congestion according to VExUS score in critically Ill patients in a general intensive care unit. J Ultrasound Med. 2025;44(9):1545\u201354.","journal-title":"J Ultrasound Med"},{"issue":"1","key":"454_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10741-018-9727-7","volume":"24","author":"A Kuriyama","year":"2019","unstructured":"Kuriyama A, Urushidani S. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis. Heart Fail Rev. 2019;24(1):31\u20139.","journal-title":"Heart Fail Rev"},{"issue":"9","key":"454_CR35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797\u2013805.","journal-title":"N Engl J Med"},{"key":"454_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jcrc.2019.04.011","volume":"52","author":"OG Rewa","year":"2019","unstructured":"Rewa OG, Bagshaw SM, Wang X, et al. The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: a multicenter, prospective, observational study. J Crit Care. 2019;52:109\u201314.","journal-title":"J Crit Care"},{"issue":"20","key":"454_CR37","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","volume":"137","author":"MA Konstam","year":"2018","unstructured":"Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation. 2018;137(20):e578\u2013622.","journal-title":"Circulation"},{"issue":"7","key":"454_CR38","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jchf.2019.03.021","volume":"7","author":"BA Borlaug","year":"2019","unstructured":"Borlaug BA, Reddy YNV. The role of the pericardium in heart failure: implications for pathophysiology and treatment. JACC Heart Fail. 2019;7(7):574\u201385.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"454_CR39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ejhf.3195","volume":"26","author":"KP Kresoja","year":"2024","unstructured":"Kresoja KP, Rosch S, Sch\u00f6ber AR, et al. Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2024;26(4):1025\u201335.","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"454_CR40","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jcin.2019.02.042","volume":"12","author":"KP Rommel","year":"2019","unstructured":"Rommel KP, Besler C, Noack T, et al. Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation. JACC Cardiovasc Interv. 2019;12(15):1423\u201334.","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"454_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1513\/AnnalsATS.201312-446FR","volume":"11","author":"CE Ventetuolo","year":"2014","unstructured":"Ventetuolo CE, Klinger JR. Management of acute right ventricular failure in the intensive care unit. Ann Am Thorac Soc. 2014;11(5):811\u201322.","journal-title":"Ann Am Thorac Soc"},{"key":"454_CR42","doi-asserted-by":"crossref","unstructured":"Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385(25):2361\u201376.","DOI":"10.1056\/NEJMra2000348"},{"issue":"38","key":"454_CR43","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"6","key":"454_CR44","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1161\/01.CIR.90.6.2780","volume":"90","author":"E Loh","year":"1994","unstructured":"Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90(6):2780\u20135.","journal-title":"Circulation"},{"issue":"6","key":"454_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/cc1069","volume":"5","author":"CD Vizza","year":"2001","unstructured":"Vizza CD, Rocca GD, Roma AD, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care. 2001;5(6):355\u201361.","journal-title":"Crit Care"},{"issue":"43","key":"454_CR46","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008402","volume":"96","author":"Q Rui","year":"2017","unstructured":"Rui Q, Jiang Y, Chen M, Zhang N, Yang H, Zhou Y. Dopamine versus norepinephrine in the treatment of cardiogenic shock: a PRISMA-compliant meta-analysis. Medicine (Baltimore). 2017;96(43):e8402.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"454_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","volume":"72","author":"B Levy","year":"2018","unstructured":"Levy B, Clere-Jehl R, Legras A, et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72(2):173\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"454_CR48","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1053\/j.jvca.2018.04.032","volume":"32","author":"AM Eskandr","year":"2018","unstructured":"Eskandr AM, Metwally AA, Abu Elkassem MS, et al. Dobutamine and nitroglycerin versus milrinone for perioperative management of pulmonary hypertension in mitral valve surgery. a randomized controlled study. J Cardiothorac Vasc Anesth. 2018;32(6):2540\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"454_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/11795468221075064","volume":"16","author":"A Shankar","year":"2022","unstructured":"Shankar A, Gurumurthy G, Sridharan L, et al. A clinical update on vasoactive medication in the management of cardiogenic shock. Clin Med Insights Cardiol. 2022;16:11795468221075064.","journal-title":"Clin Med Insights Cardiol"},{"issue":"4","key":"454_CR50","first-page":"394","volume":"39","author":"RG Jung","year":"2023","unstructured":"Jung RG, Di Santo P, Mathew R, et al. Arrhythmic events and mortality in patients with cardiogenic shock on inotropic support: results of the DOREMI randomized trial. Can J Cardiol. 2023;39(4):394\u2013402.","journal-title":"Can J Cardiol"},{"issue":"15","key":"454_CR51","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","volume":"143","author":"TD Henry","year":"2021","unstructured":"Henry TD, Tomey MI, Tamis-Holland JE, et al. Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2021;143(15):e815\u201329.","journal-title":"Circulation"},{"key":"454_CR52","doi-asserted-by":"crossref","unstructured":"Mathew R, Di Santo P, Jung RG, et al. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med. 2021;385(6):516\u2013525","DOI":"10.1056\/NEJMoa2026845"},{"issue":"11","key":"454_CR53","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.healun.2024.06.012","volume":"43","author":"A Kochar","year":"2024","unstructured":"Kochar A, Vallabhajosyula S, John K, et al. Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: insights from the Cardiogenic Shock Working Group. J Heart Lung Transplant. 2024;43(11):1846\u201356.","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"454_CR54","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","volume":"44","author":"V L\u00e9opold","year":"2018","unstructured":"L\u00e9opold V, Gayat E, Pirracchio R, et al. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med. 2018;44(6):847\u201356.","journal-title":"Intensive Care Med"},{"issue":"1","key":"454_CR55","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","volume":"20","author":"T Tarvasm\u00e4ki","year":"2016","unstructured":"Tarvasm\u00e4ki T, Lassus J, Varpula M, et al. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016;20(1):208.","journal-title":"Crit Care"},{"issue":"3","key":"454_CR56","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","volume":"39","author":"B Levy","year":"2011","unstructured":"Levy B, Perez P, Perny J, Thivilier C, Gerard A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: a prospective, randomized pilot study. Crit Care Med. 2011;39(3):450\u20135.","journal-title":"Crit Care Med"},{"issue":"11","key":"454_CR57","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","volume":"45","author":"JA Russell","year":"2019","unstructured":"Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive Care Med. 2019;45(11):1503\u201317. https:\/\/doi.org\/10.1007\/s00134-019-05801-z.","journal-title":"Intensive Care Med"},{"issue":"4","key":"454_CR58","first-page":"384","volume":"25","author":"B Levy","year":"2019","unstructured":"Levy B, Buzon J, Kimmoun A. Inotropes and vasopressors use in cardiogenic shock: when, which and how much? Curr Opin Crit Care. 2019;25(4):384\u201390.","journal-title":"Curr Opin Crit Care"},{"key":"454_CR59","doi-asserted-by":"crossref","unstructured":"Hu K, Mathew R. Inotrope and vasopressor use in cardiogenic shock: what, when and why? Curr Opin Crit Care. 2022;28(4):419\u201325.","DOI":"10.1097\/MCC.0000000000000957"},{"key":"454_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ahj.2025.03.009","volume":"286","author":"D Sarma","year":"2025","unstructured":"Sarma D, Smith R, Padkins M, et al. Association between vasopressin administration and mortality in patients with cardiogenic shock. Am Heart J. 2025;286:88\u201396.","journal-title":"Am Heart J"},{"issue":"20","key":"454_CR61","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.117.032054","volume":"137","author":"BW Roberts","year":"2018","unstructured":"Roberts BW, Kilgannon JH, Hunter BR, et al. Association between early hyperoxia exposure after resuscitation from cardiac arrest and neurological disability: prospective multicenter protocol-directed cohort study. Circulation. 2018;137(20):2114\u201324.","journal-title":"Circulation"},{"issue":"8","key":"454_CR62","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/jamacardio.2020.1274","volume":"5","author":"S van Diepen","year":"2020","unstructured":"van Diepen S, Hochman JS, Stebbins A, Alviar CL, Alexander JH, Lopes RD. Association between delays in mechanical ventilation initiation and mortality in patients with refractory cardiogenic shock. JAMA Cardiol. 2020;5(8):965\u20137.","journal-title":"JAMA Cardiol"},{"issue":"55","key":"454_CR63","volume":"1","author":"C Mehta","year":"2025","unstructured":"Mehta C, Shin A, Osorio B, et al. Management of non-cardiac organ failure in cardiogenic shock. Am Heart J Plus. 2025;1(55):100549.","journal-title":"Am Heart J Plus"},{"issue":"2","key":"454_CR64","first-page":"300","volume":"36","author":"CL Alviar","year":"2020","unstructured":"Alviar CL, Rico-Mesa JS, Morrow DA, et al. Positive pressure ventilation in cardiogenic shock: review of the evidence and practical advice for patients with mechanical circulatory support. Can J Cardiol. 2020;36(2):300\u201312.","journal-title":"Can J Cardiol"},{"issue":"2","key":"454_CR65","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4187\/respcare.10811","volume":"68","author":"GA Cortes-Puentes","year":"2023","unstructured":"Cortes-Puentes GA, Gattinoni L, Marini JJ. Physiology-based approach to PEEP titration in COVID-19 ARDS. Respir Care. 2023;68(2):290\u20132.","journal-title":"Respir Care"},{"key":"454_CR66","doi-asserted-by":"crossref","unstructured":"Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253\u201363.","DOI":"10.1164\/rccm.19511erratum"},{"issue":"4","key":"454_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2022.100120","volume":"1","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC, Rayfield C, Soussi S, et al. Advances in the staging and phenotyping of cardiogenic shock: part 1 of 2. JACC Adv. 2022;1(4):100120.","journal-title":"JACC Adv"},{"issue":"13","key":"454_CR68","first-page":"e771","volume":"151","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, et al. ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151(13):e771\u2013862.","journal-title":"Circulation"},{"key":"454_CR69","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287\u201396.","DOI":"10.1056\/NEJMoa1208410"},{"key":"454_CR70","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Thelemann N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II Trial. Circulation. 2019;139(3):395\u2013403.","DOI":"10.1161\/CIRCULATIONAHA.118.038201"},{"key":"454_CR71","doi-asserted-by":"crossref","unstructured":"M\u00f8ller JE, Engstr\u00f8m T, Jensen LO, et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med. 2024;390(15):1382\u20131393.","DOI":"10.1056\/NEJMoa2312572"},{"issue":"3","key":"454_CR72","first-page":"403","volume":"102","author":"SH Patlolla","year":"2023","unstructured":"Patlolla SH, Gilbert ON, Belford PM, et al. Escalation strategies, management, and outcomes of acute myocardial infarction-cardiogenic shock patients receiving percutaneous left ventricular support. Catheter Cardiovasc Interv. 2023;102(3):403\u201314.","journal-title":"Catheter Cardiovasc Interv"},{"key":"454_CR73","doi-asserted-by":"crossref","unstructured":"Jentzer JC, Noseworthy PA, Kashou AH, et al. Multidisciplinary critical care management of electrical storm: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(22):2189\u20132206.","DOI":"10.1016\/j.jacc.2023.03.424"},{"key":"454_CR74","doi-asserted-by":"crossref","unstructured":"Somberg JC, Bailin SJ, Haffajee CI, et al. Amio-aqueous investigators. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol. 2002;90(8):853\u20139.","DOI":"10.1016\/S0002-9149(02)02707-8"},{"issue":"10","key":"454_CR75","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15(10):e190\u2013252.","journal-title":"Heart Rhythm"},{"issue":"5","key":"454_CR76","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.chest.2022.10.024","volume":"163","author":"D Wagner","year":"2023","unstructured":"Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RW. Comparative effectiveness of amiodarone and lidocaine for the treatment of in-hospital cardiac arrest. Chest. 2023;163(5):1109\u201319.","journal-title":"Chest"},{"key":"454_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2025.110515","volume":"208","author":"T Smida","year":"2025","unstructured":"Smida T, Crowe R, Price BS, et al. A retrospective \u2018target trial emulation\u2019 comparing amiodarone and lidocaine for adult out-of-hospital cardiac arrest resuscitation. Resuscitation. 2025;208:110515.","journal-title":"Resuscitation"},{"key":"454_CR78","doi-asserted-by":"crossref","unstructured":"Ortiz M, Mart\u00edn A, Arribas F, et al. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J. 2017;38(17):1329\u20131335.","DOI":"10.1093\/eurheartj\/ehw230"},{"issue":"5","key":"454_CR79","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1253\/circj.CJ-09-0932","volume":"74","author":"S Komura","year":"2010","unstructured":"Komura S, Chinushi M, Furushima H, et al. Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Circ J. 2010;74(5):864\u20139.","journal-title":"Circ J"},{"issue":"1","key":"454_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0002-9149(96)00224-X","volume":"78","author":"AP Gorgels","year":"1996","unstructured":"Gorgels AP, van den Dool A, Hofs A, et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol. 1996;78(1):43\u20136.","journal-title":"Am J Cardiol"},{"issue":"40","key":"454_CR81","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997\u20134126.","journal-title":"Eur Heart J"},{"issue":"17","key":"454_CR82","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","volume":"71","author":"S Chatzidou","year":"2018","unstructured":"Chatzidou S, Kontogiannis C, Tsilimigras DI, et al. Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol. 2018;71(17):1897\u20131906.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"454_CR83","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.120.047468","volume":"142","author":"RP Martins","year":"2020","unstructured":"Martins RP, Urien JM, Barbarot N, et al. Effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs. Circulation. 2020;142(16):1599\u2013601.","journal-title":"Circulation"},{"key":"454_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5158362","volume":"2022","author":"Q Zhong","year":"2022","unstructured":"Zhong Q, Kumar A, Deshmukh A, Bennett C. Dexmedetomidine reduces incidences of ventricular arrhythmias in adult patients: a meta-analysis. Cardiol Res Pract. 2022;2022:5158362.","journal-title":"Cardiol Res Pract"},{"key":"454_CR85","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.12.015","volume":"34","author":"ED Wittwer","year":"2020","unstructured":"Wittwer ED, Radosevich MA, Ritter M, Cha YM. Stellate ganglion blockade for refractory ventricular arrhythmias: implications of ultrasound-guided technique and review of the evidence. J Cardiothorac Vasc Anesth. 2020;34:8: 2245-2252.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"454_CR86","doi-asserted-by":"crossref","unstructured":"Vallabhajosyula S, Dunlay SM, Prasad A, et al. Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock. J Am Coll Cardiol. 2019;;73(14):1781\u20131791.","DOI":"10.1016\/j.jacc.2019.01.053"},{"key":"454_CR87","doi-asserted-by":"crossref","unstructured":"Vallabhajosyula S. End-organ injury and failure: the true DanGer in cardiogenic shock. Circulation. 2024;150(25):2004\u20136.","DOI":"10.1161\/CIRCULATIONAHA.124.072571"},{"key":"454_CR88","doi-asserted-by":"crossref","unstructured":"Jentzer JC, Rali AS, Miller PE. Stop treating the numbers: treat the patient! JACC Heart Fail. 2025;13(9):102560.","DOI":"10.1016\/j.jchf.2025.102560"},{"key":"454_CR89","doi-asserted-by":"crossref","unstructured":"Mullens W, Dauw J, Martens P, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022;387(13):1185\u20131195.","DOI":"10.1056\/NEJMoa2203094"},{"issue":"24","key":"454_CR90","first-page":"07740","volume":"S0735\u20131097","author":"VK Ton","year":"2024","unstructured":"Ton VK, Li S, John K, et al. Serial shock severity assessment within 72 hours after diagnosis: a cardiogenic shock working group report. J Am Coll Cardiol. 2024;S0735\u20131097(24):07740\u20134.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"454_CR91","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jacc.2025.01.031","volume":"85","author":"V Ton","year":"2025","unstructured":"Ton V, Li S, Kapur N. Reply: optimizing care during the \u201cGolden Day of Shock.\u201d JACC. 2025;85(13):1469.","journal-title":"JACC"},{"issue":"0","key":"454_CR92","volume":"0","author":"SS Naidu","year":"2025","unstructured":"Naidu SS, Nathan S, Basir M, Baran D, Marbach J, Grimes C. SCAI door to lactate clearance (SCAI DLC) cardiogenic shock initiative: definition, hypothesis, and call to action. JSCAI. 2025;0(0):103996.","journal-title":"JSCAI"},{"key":"454_CR93","doi-asserted-by":"crossref","unstructured":"Mehta C, Has P, Osorio B, et al. Serial severity assessment in advanced stages of AMI-cardiogenic shock requiring micro-axial flow pump support. J Soc Cardiovasc Angiogr Interven. 2025;4(5):102565.","DOI":"10.1016\/j.jscai.2025.102565"},{"issue":"5","key":"454_CR94","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.011736","volume":"17","author":"SM Patel","year":"2024","unstructured":"Patel SM, Berg DD, Bohula EA, et al. Early serial assessment of aggregate vasoactive support and mortality in cardiogenic shock: insights from the critical care cardiology trials network registry. Circ Heart Fail. 2024;17(5):e011736.","journal-title":"Circ Heart Fail"},{"key":"454_CR95","doi-asserted-by":"crossref","unstructured":"Geller BJ, Sinha SS, Kapur NK, et al. Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2022;146(6):e50\u2013e68.","DOI":"10.1161\/CIR.0000000000001076"},{"key":"454_CR96","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.carrev.2024.03.024","volume":"66","author":"AD Belur","year":"2024","unstructured":"Belur AD, Mehta A, Bansal M, et al. Palliative care in the cardiovascular intensive care unit: a systematic review of current literature. Cardiovasc Revasc Med. 2024;66:68\u201373.","journal-title":"Cardiovasc Revasc Med"},{"issue":"15","key":"454_CR97","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.011954","volume":"8","author":"S Vallabhajosyula","year":"2019","unstructured":"Vallabhajosyula S, Prasad A, Dunlay SM, et al. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15-year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc. 2019;8(15):e011954.","journal-title":"J Am Heart Assoc"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-026-00454-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:02:45Z","timestamp":1788411765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-026-00454-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1007\/s40119-026-00454-8","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J Dawn Abbott receives research funding from Boston Scientific, Shockwave, Novo Nordisk, and Med Alliance, and serves as a consultant for Abbott, Medtronic, Boston Scientific, and Recor. Chirag Mehta,\u00a0Sahas Chandragiri,\u00a0Carl Atallah, Heena Asnani, Aryan Mehta, Brian Welling, Colleen McCarthy, Alexander Sweeting, Howard A Cooper, Srihari S Naidu and\u00a0Saraschandra Vallabhajosyula have nothing to disclose.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}